BUSINESS REGISTRATION NUMBER
BRN 65743918
Live

INNOBIOPHARM LIMITED

盈諾百有限公司

Registry Verified: 2026-10-08
Inquiries: 111 Views
Jurisdiction: Hong Kong, China

INNOBIOPHARM LIMITED (盈諾百有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622), legally classified as a Private company limited by shares. Its official Company Registration Number (CR No. / CRN) is 2335474, and Business Registration Number (BRN) is 65743918. Incorporated on 2016-01-27, the entity has maintained continuous statutory operations for 10 years and 9 months, currently holding an active legal status of Live. The registered office is situated at ROOM 2103, 21/F, FUTURA PLAZA, 111 HOW MING STREET, KWUN TONG, KOWLOON, HONG KONG. Regarding statutory filings, pursuant to Section 662 of the Companies Ordinance (Cap. 622), its annual return filing window falls between Jan 27 – Mar 10 (within 42 days after its incorporation anniversary), with the latest Annual Return (Form NAR1) officially filed on 2026-01-27; a total of 10 statutory filings (spanning 2021–2026, latest filed on 2026-01-27) are indexed in the registry, comprising 6 Annual Return(s) (NAR1), 2 officer/secretary change notice(s) (ND2A).

I. Statutory Registry Records & Hong Kong Virtual Office Background Verification

Official Chinese Name 盈諾百有限公司 Official English Name INNOBIOPHARM LIMITED
Company Reg No. (CRN) 2335474 Business Reg No. (BRN / UBI)
65743918
HK Unique Business ID · US IRS Form W-8BEN-E Foreign TIN
Incorporation Date 2016-01-27 Company Category Private company limited by shares
Current Legal Status Live Statutory Filing Cycle
2027-01-27(2026 Return Filed)
42d NAR1 Window: Jan 27 – Mar 10 · Latest NAR1: 2026-01-27
Registered Office Address
ROOM 2103, 21/F, FUTURA PLAZA, 111 HOW MING STREET, KWUN TONG, KOWLOON, HONG KONGFutura Plaza · Kwun Tong · 1,489 Co-Located Entities →
Significant Controllers (SCR) Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report.

II. Companies Registry Document Retrieval(Annual Return NAR1 & ND2A Filings)

#Filing DateDocument No.Document NamePagesTariffAction
12026-01-2770005382309
NAR1
Annual Return (2026) (English)Latest Shareholders & Directors
9HK$ 28
22025-01-2770004344844
NAR1
Annual Return (2025) (English)
9HK$ 28
32024-07-0522902870587
DOC
CR Statutory Filing Document (English)
3HK$ 20
42024-01-2970003546929
NAR1
Annual Return (2024) (English)
9HK$ 28
52023-12-27SH000714759
BRN_REF
Reference Document for Business Registration Number as UBI
1HK$ 30
62023-09-1270003332252
ND2A
Notice of Change of Company Secretary and Director (English)
3HK$ 20
72023-01-2770002941946
NAR1
Annual Return (2023) (English)
9HK$ 28
82023-01-1070002925133
ND2B
Notice of Change of Company Secretary and Director (Particulars) (English)
3HK$ 20
92022-01-27T0002444047
NAR1
Annual Return (2022) (English)
9HK$ 28
102021-01-27T0002010021
NAR1
Annual Return (2021) (English)
9HK$ 28

III. Commercial Due Diligence & Regulatory Risk Screening

Cross-screened across 32 HK statutory regulators, court dockets & sanctions registers: 0 licences, 0 public litigation/HCCW records, 0 sanctions hits.

IV. Corporate Statutory Dossier & Legal Status FAQ

Yes. INNOBIOPHARM LIMITED is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2016-01-27 (operating for 10 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: October 2026).

The statutory primary identifiers for INNOBIOPHARM LIMITED are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [65743918] (effective from 27 December 2023 under Cap. 310, this 8-digit number serves as the unified corporate identifier and the official Foreign TIN for US IRS Form W-8BEN-E, Line 9b); 2. Company Registration Number (CRN): [2335474] (Cap. 622 incorporation archive number; do not enter the 7-digit CRN as the tax ID). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.

Yes. Statutory indexing confirms that INNOBIOPHARM LIMITED has accumulated 10 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2026-01-27: Form NAR1 - Annual Return (2026) (English)). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.

The statutory registered office of INNOBIOPHARM LIMITED on official record is situated at: [ROOM 2103, 21/F, FUTURA PLAZA, 111 HOW MING STREET, KWUN TONG, KOWLOON, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.

V. Similar Trade Names & Industry Directory

Retrieve Filings